How does Dexycu work to treat inflammation associated with cataract surgery?
Medically reviewed by Drugs.com. Last updated on Feb 26, 2020.
Dexycu contains dexamethasone, which is a corticosteroid that prevents the release of substances in the body that cause inflammation.
Dexycu (dexamethasone) from Icon Bioscience Inc., is an injectable, long-acting, corticosteroid intraocular suspension administered into the posterior (rear) chamber of the eye to lower inflammation (swelling) after cataract surgery. Dexycu is given as a single injection at the conclusion of surgery.
What is the advantage of Dexycu injection over eye drops?
Because Dexycu is given as a single, long-acting injection after cataract surgery, patients would not need to self-administer anti-inflammatory eye drops several times daily over a period of weeks after eye surgery. This may be especially advantageous in older patients, and lower the risk of non-compliance and dosing errors linked with frequent eye drops following cataract surgery. However, other eye drops, such as antibiotics, may be needed after cataract surgery.
Related Medical Questions
- What is the best way to reduce swelling in your face?
- How long should Brilinta be held/stopped before surgery?
- What are the advantages of using the Dextenza ophthalmic insert after eye surgery?
- What is the drug Bromsite used for?
- What is the difference between Inveltys, Lotemax and Alrex?
- Dexycu Information for Consumers
- Dexycu Information for Healthcare Professionals (includes dosage details)
- Side Effects of Dexycu (detailed)